Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simcere Pharmaceutical Group Limited (HK:2096)
HKEX:2096
Simcere Pharmaceutical Group Limited (2096) Stock Forecast & Price Target
2 Followers
See the Price Targets and Ratings of:
2096 Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2096 Stock 12 Month Forecast
Average Price Target
HK$8.20
▲(44.62% Upside)
| Highest Price TargetHK$8.20 | Average Price TargetHK$8.20 | Lowest Price TargetHK$8.20 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
CMB International Securities
HK$8.15
Buy
43.74%
Upside
Reiterated
08/23/23
We expect Cosela to be added to the NRDL for ES-SCLC in early 2024. In addition, the Ph3 trial of Cosela in TNBC will release data in 1H24. The Company is also exploring the potential of Cosela in combination with ADC or IO drugs. Besides the commercialized assets, the Company recently in- licensed CMAB009 (EGFR) which is currently under the NDA review by CDE for CRC. CMAB009 could potentially become the first domestic EGFR mAb in China.
Best Analysts Covering Simcere Pharmaceutical Group Limited
Which Analyst Should I Follow If I Want to Buy HK:2096 and Sell After:
1 Month
3 Months
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+6.40%
reiterated a buy rating 4 months ago
Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2096 Analyst Recommendation Trends
Rating
Aug 23
Mar 24
May 24
Strong Buy
0
1
1
Buy
1
1
2
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
3
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
2096 Financial Forecast
2096 Stock Forecast FAQ
What is HK:2096’s average 12-month price target, according to analysts?
Based on analyst ratings, Simcere Pharmaceutical Group Limited’s 12-month average price target is HK$8.20.
What is HK:2096’s upside potential, based on the analysts’ average price target?
Simcere Pharmaceutical Group Limited has 44.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Simcere Pharmaceutical Group Limited a Buy, Sell or Hold?
Simcere Pharmaceutical Group Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Simcere Pharmaceutical Group Limited’s share price target?
The average share price target for Simcere Pharmaceutical Group Limited is HK$8.20. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$8.20 ,and the lowest forecast is HK$8.20. The average share price target represents 44.62% Increase from the current price of HK$5.67.
The highest analyst share price target is HK$8.20 ,and the lowest forecast is HK$8.20. The average share price target represents 44.62% Increase from the current price of HK$5.67.
What do analysts say about Simcere Pharmaceutical Group Limited?
Simcere Pharmaceutical Group Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Simcere Pharmaceutical Group Limited?
To buy shares of HK:2096, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.